Neo-Naclex-K modified-release tablets (Mercury Pharma Group Ltd)

ID
3638211000001100
Virtual product
Bendroflumethiazide 2.5mg / Potassium chloride 630mg (potassium 8.4mmol) modified-release tablets
Name
Neo-Naclex-K modified-release tablets
Description
Neo-Naclex-K modified-release tablets (Mercury Pharma Group Ltd)
Supplier
Mercury Pharma Group Ltd
Licensed as
Medicines - MHRA/EMA
Restrictions on availability
Not available
Licensed route
Oral